279 related articles for article (PubMed ID: 27228655)
21. Genetic variability in the SNCA gene influences alpha-synuclein levels in the blood and brain.
Fuchs J; Tichopad A; Golub Y; Munz M; Schweitzer KJ; Wolf B; Berg D; Mueller JC; Gasser T
FASEB J; 2008 May; 22(5):1327-34. PubMed ID: 18162487
[TBL] [Abstract][Full Text] [Related]
22. SNCA: major genetic modifier of age at onset of Parkinson's disease.
Brockmann K; Schulte C; Hauser AK; Lichtner P; Huber H; Maetzler W; Berg D; Gasser T
Mov Disord; 2013 Aug; 28(9):1217-21. PubMed ID: 23674386
[TBL] [Abstract][Full Text] [Related]
23. Differential expression of α-synuclein splice variants in the brain of alcohol misusers: Influence of genotype.
Janeczek P; Brooker C; Dodd PR; Lewohl JM
Drug Alcohol Depend; 2015 Oct; 155():284-92. PubMed ID: 26297298
[TBL] [Abstract][Full Text] [Related]
24. Interaction between SNCA gene polymorphisms and T2DM with Parkinson's disease.
Liu Y; Bai H; Gen S; Zhang H; Wang S; Hua L; Yang X; Zhang S; Li J; Wang Y
Acta Neurol Scand; 2020 Nov; 142(5):443-448. PubMed ID: 32484913
[TBL] [Abstract][Full Text] [Related]
25. Association of rs356219 and rs3822086 polymorphisms with the risk of Parkinson's disease: A meta-analysis.
Hou B; Zhang X; Liu Z; Wang J; Xie A
Neurosci Lett; 2019 Sep; 709():134380. PubMed ID: 31325583
[TBL] [Abstract][Full Text] [Related]
26. Alpha-synuclein polymorphisms are associated with Parkinson's disease in a Saskatchewan population.
Rajput A; Vilariño-Güell C; Rajput ML; Ross OA; Soto-Ortolaza AI; Lincoln SJ; Cobb SA; Heckman MG; Farrer MJ; Rajput A
Mov Disord; 2009 Dec; 24(16):2411-4. PubMed ID: 19890971
[TBL] [Abstract][Full Text] [Related]
27. Multiple candidate gene analysis identifies alpha-synuclein as a susceptibility gene for sporadic Parkinson's disease.
Mizuta I; Satake W; Nakabayashi Y; Ito C; Suzuki S; Momose Y; Nagai Y; Oka A; Inoko H; Fukae J; Saito Y; Sawabe M; Murayama S; Yamamoto M; Hattori N; Murata M; Toda T
Hum Mol Genet; 2006 Apr; 15(7):1151-8. PubMed ID: 16500997
[TBL] [Abstract][Full Text] [Related]
28. α-Synuclein rs356219 polymorphisms in patients with Gaucher disease and Parkinson disease.
Altarescu G; Ioscovich D; Alcalay RN; Zimran A; Elstein D
Neurosci Lett; 2014 Sep; 580():104-7. PubMed ID: 25111979
[TBL] [Abstract][Full Text] [Related]
29. SNCA, MAPT, and GSK3B in Parkinson disease: a gene-gene interaction study.
Wider C; Vilariño-Güell C; Heckman MG; Jasinska-Myga B; Ortolaza-Soto AI; Diehl NN; Crook JE; Cobb SA; Bacon JA; Aasly JO; Gibson JM; Lynch T; Uitti RJ; Wszolek ZK; Farrer MJ; Ross OA
Eur J Neurol; 2011 Jun; 18(6):876-81. PubMed ID: 21159074
[TBL] [Abstract][Full Text] [Related]
30. A Comprehensive Analysis of the Association Between
Zhang Y; Shu L; Sun Q; Pan H; Guo J; Tang B
Front Mol Neurosci; 2018; 11():391. PubMed ID: 30410434
[No Abstract] [Full Text] [Related]
31. SNCA Gene, but Not MAPT, Influences Onset Age of Parkinson's Disease in Chinese and Australians.
Huang Y; Wang G; Rowe D; Wang Y; Kwok JB; Xiao Q; Mastaglia F; Liu J; Chen SD; Halliday G
Biomed Res Int; 2015; 2015():135674. PubMed ID: 25960998
[TBL] [Abstract][Full Text] [Related]
32. Lack of replication of a previously reported association between polymorphism in the 3'UTR of the alpha-synuclein gene and Parkinson's disease in Chinese subjects.
Hu FY; Hu WB; Liu L; Yu LH; Xi J; He XH; Zhu MR; Liu ZL; Xu YM
Neurosci Lett; 2010 Jul; 479(1):31-3. PubMed ID: 20478361
[TBL] [Abstract][Full Text] [Related]
33. Parkinson's disease correlates with promoter methylation in the α-synuclein gene.
Pihlstrøm L; Berge V; Rengmark A; Toft M
Mov Disord; 2015 Apr; 30(4):577-80. PubMed ID: 25545759
[TBL] [Abstract][Full Text] [Related]
34. Variants in SNCA Gene Are Associated with Parkinson's Disease Risk and Cognitive Symptoms in a Brazilian Sample.
Campêlo CLC; Cagni FC; de Siqueira Figueredo D; Oliveira LG; Silva-Neto AB; Macêdo PT; Santos JR; Izídio GS; Ribeiro AM; de Andrade TG; de Oliveira Godeiro C; Silva RH
Front Aging Neurosci; 2017; 9():198. PubMed ID: 28676755
[TBL] [Abstract][Full Text] [Related]
35. Family-based association study on functional α-synuclein polymorphisms in attention-deficit/hyperactivity disorder.
Gerlach M; Sharma M; Romanos M; Lesch KP; Walitza S; Conzelmann HA; Krüger R; Renner TJ
Atten Defic Hyperact Disord; 2019 Mar; 11(1):107-111. PubMed ID: 30927235
[TBL] [Abstract][Full Text] [Related]
36. [Frequency of single nucleotide polymorphisms and alpha-synuclein haplotypes associated with sporadic Parkinson's disease in the Mexican population].
Davila-Ortiz de Montellano DJ; Rodriguez-Violante M; Fresan A; Monroy-Jaramillo N; Yescas-Gomez P
Rev Neurol; 2016 Oct; 63(8):345-350. PubMed ID: 27699750
[TBL] [Abstract][Full Text] [Related]
37. Levels of alpha-synuclein mRNA in sporadic Parkinson disease patients.
Chiba-Falek O; Lopez GJ; Nussbaum RL
Mov Disord; 2006 Oct; 21(10):1703-8. PubMed ID: 16795004
[TBL] [Abstract][Full Text] [Related]
38. The effect of SNCA 3' region on the levels of SNCA-112 splicing variant.
McCarthy JJ; Linnertz C; Saucier L; Burke JR; Hulette CM; Welsh-Bohmer KA; Chiba-Falek O
Neurogenetics; 2011 Feb; 12(1):59-64. PubMed ID: 21046180
[TBL] [Abstract][Full Text] [Related]
39. SNCA rs356182 variant increases risk of sporadic Parkinson's disease in ethnic Chinese.
Cheng L; Wang L; Li NN; Yu WJ; Sun XY; Li JY; Zhou D; Peng R
J Neurol Sci; 2016 Sep; 368():231-4. PubMed ID: 27538639
[TBL] [Abstract][Full Text] [Related]
40. Variants in the SNCA gene associate with motor progression while variants in the MAPT gene associate with the severity of Parkinson's disease.
Wang G; Huang Y; Chen W; Chen S; Wang Y; Xiao Q; Liu J; Fung VS; Halliday G; Chen S
Parkinsonism Relat Disord; 2016 Mar; 24():89-94. PubMed ID: 26776090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
